gray glp-1 Receptor Agonists Linked to Improved Survival Outcomes in Breast Cancer GLP-1 Agonists: A Comprehensive Overview

Atypical (second-generation) antipsychotics Drug Safety Update

If appetite regulation, fat loss, and metabolic improvement are occurring without excessive side effects, a slower titration may be clinically reasonable

The authors describe the rationale of their study as looking at the real-world outcomes of the use of GLP-1 agonists both the positive effects and adverse outcomes

Barkley lost nearly 50 pounds when he initially started on a GLP-1 medication, but like many Americans, struggled to stay on treatment due to ongoing supply and access issues

In: Boothe DM

Our results add to the growing body of evidence supporting the cardioprotective effects of GLP-1 agonists and highlight their potential as a promising therapeutic strategy for RV dysfunction [12, 13]